Amicus Therapeutics Inc. buy Citigroup Inc.
Start price
17.12.25
/
50%
€9.40
Target price
17.12.26
€14.47
Performance (%)
28.72%
Price
17.02.26
?
Summary
This prediction is currently active. The prediction currently has a performance of 28.72%. This prediction currently runs until 17.12.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amicus Therapeutics Inc. | 0.840% | 0.840% |
| iShares Core DAX® | -0,82 % | -2,03 % |
| iShares Nasdaq 100 | -1,74 % | -5,35 % |
| iShares Nikkei 225® | 1,21 % | 6,38 % |
| iShares S&P 500 | -1,17 % | -3,46 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics (NASDAQ:FOLD) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $17.00 price target on the stock.
Ratings data for FOLD provided by MarketBeat